LCM
PTCT icon

Landscape Capital Management’s PTC Therapeutics PTCT Stock Holding History

Landscape Capital Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
+14,958
New +$1.08M 0.08% 358

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Landscape Capital Management's PTCT Position: Q2 2026 in Review

Landscape Capital Management opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 14,958 shares worth $1.22M. The stake represents 0.08% of the portfolio and ranks #358 among its holdings.

382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Landscape Capital Management held 14,958 shares of PTC Therapeutics worth $1.22M as of Q2 2026.
  • PTC Therapeutics was a new Landscape Capital Management position in Q2 2026.
  • PTC Therapeutics made up 0.08% of Landscape Capital Management's portfolio in Q2 2026, its #358 holding.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.